0001683168-23-004822.txt : 20230712
0001683168-23-004822.hdr.sgml : 20230712
20230712193812
ACCESSION NUMBER: 0001683168-23-004822
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230710
FILED AS OF DATE: 20230712
DATE AS OF CHANGE: 20230712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ziebell Mark R
CENTRAL INDEX KEY: 0001552642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 231085548
MAIL ADDRESS:
STREET 1: 14282 FRANKLIN AVENUE
CITY: TUSTIN
STATE: CA
ZIP: 92780
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0407
4
2023-07-10
0
0000704562
Avid Bioservices, Inc.
CDMO
0001552642
Ziebell Mark R
14191 MYFORD ROAD
TUSTIN
CA
92780
0
1
0
0
V. P., General Counsel
0
Common Stock, $0.001 par value
2023-07-10
4
M
0
14291
A
63464
D
Common Stock, $0.001 par value
2023-07-11
4
S
0
5015
13.8594
D
58449
D
Restricted Stock Units
2023-07-10
4
M
0
3778
0.0000
D
Common Stock
3778
55002
D
Restricted Stock Units
2023-07-10
4
M
0
10513
0.0000
D
Common Stock
10513
44489
D
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs described in footnotes 4 and 5. This sale does not represent a discretionary trade by the reporting person.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $13.7609 to $13.86. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
RSUs granted to the reporting person on July 10, 2020, vest in four (4) equal annual installments beginning July 10, 2021, and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
RSUs granted to the reporting person on July 10, 2019, vested in four (4) equal annual installments and was fully-vested as of July 10, 2023.
/s/ Mark R. Ziebell
2023-07-12